What is the average price target for BIOMERIEUX (BIM.PA) stock?
17 analysts have analysed BIM.PA and the average price target is 119.71 EUR. This implies a price increase of 32.72% is expected in the next year compared to the current price of 90.2.
BIOMERIEUX (BIM.PA) Forecast, Price Target & Analyst Ratings
EPA:BIM • FR0013280286
Current stock price
90.2 EUR
+0.65 (+0.73%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOMERIEUX (BIM.PA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
€119.71
Upside
+ 32.72%
From current price of €90.20 to mean target of €119.71, Based on 17 analyst forecasts
Low
€101.00
Median
€117.30
High
€144.90
Price Target Revisions
1 Month
-1.15%
3 Months
-6.73%
Price Target Summary
17 Wall Street analysts provided a forecast for the next 12 months for BIM.PA. The average price target is 119.71 EUR. This implies a price increase of 32.72% is expected in the next year compared to the current price of 90.2.
The average price target has been revised downward by 6.73% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
74.12%
BIM.PA was analyzed by 17 analysts. The buy percentage consensus is at 74. So analysts seem to be have mildly positive about BIM.PA.
In the previous month the buy percentage consensus was at a similar level.
BIM.PA was analyzed by 17 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-07-17 | STIFEL EUROPE | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- Apr 23, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2032
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 3.675B 2.38% | 3.98B 8.31% | 4.07B 2.26% | 4.295B 5.53% | 4.617B 7.50% | 4.913B 6.41% | 5.294B 7.75% | 5.061B -4.40% | 5.935B | |
| EBITDA YoY % growth | 731.2M 11.77% | 936.9M 28.13% | 959.7M 2.43% | 1.073B 11.81% | 1.209B 12.67% | 1.314B 8.68% | 1.424B 8.37% | N/A | 1.49B | |
| EBIT YoY % growth | 561.1M -4.44% | 611.7M 9.02% | 521.3M -14.78% | 750.24M 43.92% | 849.8M 13.27% | 940.7M 10.70% | 1.09B 15.87% | 928.52M -14.81% | N/A | |
| Operating Margin | 15.27% | 15.37% | 12.81% | 17.47% | 18.41% | 19.15% | 20.59% | 18.35% | N/A | |
| EPS YoY % growth | N/A -3.16% | 3.86 4.34% | 3.65 -5.44% | 4.88 33.58% | 5.51 13.09% | 6.07 10.11% | 6.88 13.24% | N/A | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
18.49%
EPS Next 5 Year
17.15%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
5.71%
Revenue Next 5 Year
4.00%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
24.49%
EBIT Next 5 Year
20.25%
BIOMERIEUX / BIM.PA Forecast FAQ
When does BIOMERIEUX (BIM.PA) report earnings?
BIOMERIEUX (BIM.PA) will report earnings on 2026-04-23.
What is the consensus rating for BIOMERIEUX (BIM.PA) stock?
The consensus rating for BIOMERIEUX (BIM.PA) is 74.1176 / 100 . This indicates that analysts generally have a positive outlook on the stock.